The Austen BioInnovation Institute in Akron (ABIA) has created its first company: a firm that’s developing a noninvasive spinal fixation system for children with scoliosis.APTO Orthopaedics’ device is designed to eliminate the need for repetitive, painful and costly surgeries for children with scoliosis, who can require up to two surgeries per year to adjust implants [...]

The Austen BioInnovation Institute in Akron (ABIA) and Lubrizol have entered into a strategic partnership that involves research and development around medical applications of polymers and specialty chemicals.The partnership gives Wickliffe, Ohio-based Lubrizol access to the ABIA’s expertise in polymers, wound care and orthopedics. The ABIA, in return, will be able to leverage Lubrizol’s experience [...]

The Austen BioInnovation Institute in Akron is collaborating with the U.S. Food and Drug Administration to share its expertise in the use of biomaterials and polymers in medical devices.The goal of the partnership is to help the FDA more effectively regulate the safety and performance of the materials when they’re used in the manufacture of [...]

The Austen BioInnovation Institute in Akron and the University of Akron are planning to launch in January a semester-long educational program aimed at women entrepreneurs. The program will provide participants with access to experts, coaching by successful entrepreneurs, contact with cutting-edge technology and support in forming companies and licensing ideas.

The Ohio Venture Association will focus on the world of biomedical technology when Frank Douglas, President and CEO of the Akron BioInnovation Institute, speaks at its upcoming lunch meeting.

A nationally-renowned medical researcher will be featured in next month’s issue of GQ Magazine as a Rock Star of Science.Dr. Frank L. Douglas says the honor was unexpected, but “a thrill.”Douglas, 67, is founder and CEO of the Austen BioInnovation Institute of Akron.Since joining ABIA in September 2009, Douglas has led an organization that is [...]

The University of Akron Research Foundation and the Austen BioInnovation Institute were awarded $1 million as winners of a federal competition designed to reward regional collaboration on innovation.

If the Austen BioInnovation Institute in Akron is to reach its goals of bringing 2,400 jobs and 60 biomedical companies to the city within 10 years, it’s likely Brian Davis will be a big reason why.

This fall, BioOhio will hold its Annual Conference in three regions on three different dates. ’Innovation Road Show’ will visit northeast Ohio on September 28, central Ohio on October 28, and southwest Ohio on November 17. At all three sites, the emphasis will be on biomedical innovation ’ defining it, discussing it, debating it, and understanding how essential it is from R&D through commercialization to market. Ample networking time will be available for Ohio’s bioscience innovators to share ideas and initiate collaborations.

The Austen BioInnovation Institute in Akron has received a $2.6 million Ohio Third Frontier grant for biomedical sensor research and commercialization. The grant is from the revamped Wright Center for Sensor Systems Engineering at Cleveland State University.